Form 8-K - Current report:
SEC Accession No. 0001104659-21-154482
Filing Date
2021-12-30
Accepted
2021-12-30 09:11:17
Documents
17
Period of Report
2021-12-30
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2136572d1_8k.htm   iXBRL 8-K 34174
2 EXHIBIT 2.1 tm2136572d1_ex2-1.htm EX-2.1 737893
3 EXHIBIT 99.1 tm2136572d1_ex99-1.htm EX-99.1 13934
7 GRAPHIC tm2136572d1_ex99-1img001.jpg GRAPHIC 3927
8 GRAPHIC tm2136572d1_ex99-1img002.jpg GRAPHIC 3927
9 GRAPHIC tm2136572d1_ex99-1img003.jpg GRAPHIC 3927
  Complete submission text file 0001104659-21-154482.txt   1130738

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20211230.xsd EX-101.SCH 3055
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20211230_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20211230_pre.xml EX-101.PRE 22379
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2136572d1_8k_htm.xml XML 3493
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 211530728
SIC: 2834 Pharmaceutical Preparations